story of the week
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial
Circulation 2021 Feb 08;[EPub Ahead of Print], N Ye, MJ Jardine, M Oshima, C Hockham, HJL Heerspink, R Agarwal, G Bakris, AE Schutte, C Arnott, TI Chang, JL Górriz, CP Cannon, DM Charytan, D de Zeeuw, A Levin, KW Mahaffey, B Neal, C Pollock, DC Wheeler, GL Di Tanna, H Cheng, V Perkovic, BL NeuenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.